Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  General Pharmaceutical

Solvay S.A.: PharmaVitae Profile


Published Date: October 2008
Published By: Datamonitor
Page Count: 141
Order Code: R313-41509
 
DescriptionTable of ContentsSimilar
Products

Introduction

This analysis examines the historical and forecast performance for Solvay in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase
  • Benchmark Solvay's performance against key rivals in the prescription pharmaceutical sector
  • See how sales growth driven by increased penetration of the US dyslidemia market will be offset by a growing generic threat and poor R&D productivity
  • Learn how Solvay plans to continue raising its operating profit margin, already improved by an increased pharma focus, by pursuing efficiency savings


Please Note: This product is delivered as a zip file

Similar Products
Pharmaceutical Alliance Management
Published Jan 2009 by Cutting Edge Information


Diabetes Market Forecast to 2013
Published Jan 2009 by Cutting Edge Information


Kenya Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Kuwait Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


France Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Bangladesh Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Study for Opportunities Assessment for Hepatitis B Therapeutics in Korea
Published Dec 2008 by Frost & Sullivan


Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan
Published Dec 2008 by Frost & Sullivan


Study for Opportunities Assessment for Hepatitis B Therapeutics in India
Published Dec 2008 by Frost & Sullivan


India Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com